• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症基因是结直肠癌的新型预后生物标志物。

Inflammatory genes are novel prognostic biomarkers for colorectal cancer.

机构信息

Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China.

Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China.

出版信息

Int J Mol Med. 2018 Jul;42(1):368-380. doi: 10.3892/ijmm.2018.3631. Epub 2018 Apr 18.

DOI:10.3892/ijmm.2018.3631
PMID:29693170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5979867/
Abstract

Inflammatory genes serve a crucial role in the pathogenesis of inflammation‑associated tumors. However, as recent studies have mainly focused on the effects of single inflammatory genes on colorectal cancer (CRC), but not on the global interactions between genes, the underlying mechanisms between inflammatory genes and CRC remain unclear. In the current study, two inflammation‑associated networks were constructed based on inflammatory genes, differentially expressed genes (DEGs) in CRC vs. normal samples, and protein‑protein interactions (PPIs). These networks included an inflammation‑related neighbor network (IRNN) and an inflammation‑related DEG network (IRDN). Notably, the results indicated that the inflammatory genes served as important CRC‑associated genes in the IRNN. Certain inflammatory genes were more likely to be network hubs and exhibited higher betweenness centralities, indicating that these inflammatory hub genes had central roles in the communication between genes in the IRNN. By contrast, in the IRDN, functional enrichment analysis revealed that genes were enriched in numerous cancer‑associated functions and pathways. Subsequently, 14 genes in a module were identified in the IRDN as the potential biomarkers associated with disease‑free survival (DFS) in CRC patients in the GSE24550 dataset, the prognosis of which was further validated using three independent datasets (GSE24549, GSE34551 and GSE103479). All 14 genes (including BCAR1, CRK, FYN, GRB2, LCP2, PIK3R1, PLCG1, PTK2, PTPN11, PTPN6, SHC1, SOS1, SRC and SYK) in this module were inflammatory genes, emphasizing the critical role of inflammation in CRC. In conclusion, these findings based on integrated inflammation‑associated networks provided a novel insight that may help elucidate the inflammation‑mediated mechanisms involved in CRC.

摘要

炎症基因在炎症相关肿瘤的发病机制中起着至关重要的作用。然而,由于最近的研究主要集中在单个炎症基因对结直肠癌(CRC)的影响上,而不是基因之间的整体相互作用,因此炎症基因与 CRC 之间的潜在机制仍不清楚。在本研究中,基于炎症基因、CRC 与正常样本之间差异表达的基因(DEGs)和蛋白质-蛋白质相互作用(PPIs)构建了两个炎症相关网络,包括一个炎症相关邻近网络(IRNN)和一个炎症相关 DEG 网络(IRDN)。值得注意的是,结果表明,炎症基因在 IRNN 中作为重要的 CRC 相关基因。某些炎症基因更有可能成为网络枢纽,并表现出较高的介数中心度,表明这些炎症枢纽基因在 IRNN 中基因之间的通讯中发挥着核心作用。相比之下,在 IRDN 中,功能富集分析表明,基因在许多癌症相关功能和途径中富集。随后,在 IRDN 中确定了一个模块中的 14 个基因作为与 GSE24550 数据集 CRC 患者无病生存(DFS)相关的潜在生物标志物,并用三个独立数据集(GSE24549、GSE34551 和 GSE103479)进一步验证了这些基因的预后。该模块中的所有 14 个基因(包括 BCAR1、CRK、FYN、GRB2、LCP2、PIK3R1、PLCG1、PTK2、PTPN11、PTPN6、SHC1、SOS1、SRC 和 SYK)均为炎症基因,强调了炎症在 CRC 中的关键作用。总之,这些基于整合炎症相关网络的研究结果提供了一个新的视角,可能有助于阐明 CRC 中涉及的炎症介导机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/a47789689c9c/IJMM-42-01-0368-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/245de8d6c85d/IJMM-42-01-0368-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/9d2a4ec8373b/IJMM-42-01-0368-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/9b4b8ad8fb75/IJMM-42-01-0368-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/851ab144e9df/IJMM-42-01-0368-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/4b0e56f266da/IJMM-42-01-0368-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/a0ba793ad216/IJMM-42-01-0368-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/cf44e91d9ed3/IJMM-42-01-0368-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/a47789689c9c/IJMM-42-01-0368-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/245de8d6c85d/IJMM-42-01-0368-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/9d2a4ec8373b/IJMM-42-01-0368-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/9b4b8ad8fb75/IJMM-42-01-0368-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/851ab144e9df/IJMM-42-01-0368-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/4b0e56f266da/IJMM-42-01-0368-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/a0ba793ad216/IJMM-42-01-0368-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/cf44e91d9ed3/IJMM-42-01-0368-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/712b/5979867/a47789689c9c/IJMM-42-01-0368-g07.jpg

相似文献

1
Inflammatory genes are novel prognostic biomarkers for colorectal cancer.炎症基因是结直肠癌的新型预后生物标志物。
Int J Mol Med. 2018 Jul;42(1):368-380. doi: 10.3892/ijmm.2018.3631. Epub 2018 Apr 18.
2
Identification of laryngeal cancer prognostic biomarkers using an inflammatory gene-related, competitive endogenous RNA network.利用炎症基因相关的竞争性内源性RNA网络鉴定喉癌预后生物标志物
Oncotarget. 2017 Feb 7;8(6):9525-9534. doi: 10.18632/oncotarget.13627.
3
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.基于整合生物信息学分析鉴定与结直肠癌患者诊断和预后相关的生物标志物。
Gene. 2019 Apr 15;692:119-125. doi: 10.1016/j.gene.2019.01.001. Epub 2019 Jan 14.
4
Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.整合基因表达谱分析探讨结直肠癌潜在的预后生物标志物。
Med Sci Monit. 2020 Jan 1;26:e918906. doi: 10.12659/MSM.918906.
5
Identification of a five-gene signature with prognostic value in colorectal cancer.鉴定结直肠癌中具有预后价值的五个基因标志物。
J Cell Physiol. 2019 Apr;234(4):3829-3836. doi: 10.1002/jcp.27154. Epub 2018 Aug 21.
6
Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.结直肠癌中预后生物标志物特征及候选药物的鉴定:系统生物学分析的见解
Medicina (Kaunas). 2019 Jan 17;55(1):20. doi: 10.3390/medicina55010020.
7
Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.嗜神经素和PC酯酶结构域家族成员4(NXPE4)及前列腺雄激素调节粘蛋白样蛋白1(PARM1)作为结直肠癌的预后生物标志物。
J Cell Biochem. 2019 Oct;120(10):18041-18052. doi: 10.1002/jcb.29107. Epub 2019 Jul 11.
8
Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.差异表达基因谱和 NEBL 的过表达表明结直肠癌患者的预后良好。
Mol Med Rep. 2018 Feb;17(2):3028-3034. doi: 10.3892/mmr.2017.8210. Epub 2017 Dec 7.
9
Identification of key genes associated with colorectal cancer based on the transcriptional network.基于转录网络鉴定与结直肠癌相关的关键基因
Pathol Oncol Res. 2015 Jul;21(3):719-25. doi: 10.1007/s12253-014-9880-9. Epub 2015 Jan 23.
10
Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNA‑ceRNA interaction network in colorectal cancer.通过构建和分析结直肠癌自噬调控的 ceRNA-ceRNA 相互作用网络鉴定自噬基因相关模块生物标志物。
Int J Oncol. 2018 Sep;53(3):1083-1093. doi: 10.3892/ijo.2018.4443. Epub 2018 Jun 18.

引用本文的文献

1
Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy.共抑制分子的泛癌分析揭示了它们在免疫治疗中的潜在预后和临床价值。
Front Immunol. 2025 Mar 24;16:1544104. doi: 10.3389/fimmu.2025.1544104. eCollection 2025.
2
Impact of obesity and diabetes on colorectal cancer in Saudi Arabia is associated with liver γ‑glutamyl transferase abnormality.肥胖和糖尿病对沙特阿拉伯结直肠癌的影响与肝脏γ-谷氨酰转移酶异常有关。
Exp Ther Med. 2024 Nov 26;29(2):23. doi: 10.3892/etm.2024.12773. eCollection 2025 Feb.
3
Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9.

本文引用的文献

1
Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.IV期结直肠癌患者根治性切除术后的最佳监测方案:一项多中心回顾性研究
Dis Colon Rectum. 2018 Jan;61(1):51-57. doi: 10.1097/DCR.0000000000000950.
2
Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model.基于 FIT 和常规筛查数据的风险调整结直肠癌筛查:风险预测模型的建立。
Br J Cancer. 2018 Jan;118(2):285-293. doi: 10.1038/bjc.2017.375. Epub 2017 Nov 2.
3
Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.
软骨素聚合因子 (CHPF) 通过 ASB2 介导的 SMAD9 泛素化促进结直肠癌的进展。
Histol Histopathol. 2024 Nov;39(11):1493-1503. doi: 10.14670/HH-18-738. Epub 2024 Mar 26.
4
Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications.氧化应激基因定义了三阴性乳腺癌的两种亚型,具有预后和治疗意义。
Front Genet. 2023 Jul 13;14:1230911. doi: 10.3389/fgene.2023.1230911. eCollection 2023.
5
Titin as a potential novel therapeutic target in colorectal cancer.肌联蛋白作为结直肠癌潜在的新型治疗靶点。
J Cell Mol Med. 2023 Oct;27(19):2937-2944. doi: 10.1111/jcmm.17866. Epub 2023 Jul 27.
6
An epithelial-mesenchymal transition-related prognostic model for colorectal cancer based on weighted gene co-expression network analysis.基于加权基因共表达网络分析的结直肠癌上皮-间质转化相关预后模型。
J Int Med Res. 2022 Dec;50(12):3000605221140683. doi: 10.1177/03000605221140683.
7
Bioinformatics analysis of the key genes in osteosarcoma metastasis and immune invasion.骨肉瘤转移和免疫侵袭关键基因的生物信息学分析
Transl Pediatr. 2022 Oct;11(10):1656-1670. doi: 10.21037/tp-22-402.
8
IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells.IFN-α/β 介导的 NK2R 表达与结肠癌细胞的恶性程度有关。
Cancer Sci. 2022 Aug;113(8):2513-2525. doi: 10.1111/cas.15397. Epub 2022 May 31.
9
Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database.基于TCGA数据库的食管鳞状细胞癌ceRNA网络中与肿瘤微环境相关的预后生物标志物的鉴定:一项生物信息学研究
Discov Oncol. 2021 Nov 1;12(1):46. doi: 10.1007/s12672-021-00442-5.
10
Clinical and molecular assessment of an onco-immune signature with prognostic significance in patients with colorectal cancer.临床和分子评估在结直肠癌患者中有预后意义的肿瘤免疫特征。
Cancer Med. 2022 Mar;11(6):1573-1586. doi: 10.1002/cam4.4568. Epub 2022 Feb 9.
粪便免疫化学检测(FIT)有助于排除在基层医疗中出现下腹部症状的患者患结直肠癌的可能性:为新的英国国家卫生与临床优化研究所(NICE)DG30诊断指南提供信息而进行的一项系统评价。
BMC Med. 2017 Oct 24;15(1):189. doi: 10.1186/s12916-017-0944-z.
4
Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations.高 MAPK 活性在结直肠癌细胞祖细胞中的致癌作用,且与 RAS 突变无关而持续存在。
Cancer Res. 2017 Apr 1;77(7):1763-1774. doi: 10.1158/0008-5472.CAN-16-2821. Epub 2017 Feb 15.
5
Inflammatory Molecule, , Deficiency Activates Macrophages to Promote Colorectal Cancer Growth through NFκB Signaling.炎症分子, 缺乏会通过 NFκB 信号激活巨噬细胞促进结直肠癌生长。
Mol Cancer Res. 2017 Apr;15(4):467-477. doi: 10.1158/1541-7786.MCR-16-0309. Epub 2017 Jan 20.
6
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.MABp1 作为一种新型抗体治疗药物用于晚期结直肠癌的随机、双盲、安慰剂对照、3 期研究。
Lancet Oncol. 2017 Feb;18(2):192-201. doi: 10.1016/S1470-2045(17)30006-2. Epub 2017 Jan 14.
7
Genetic variation in PPARGC1A may affect the role of diet-associated inflammation in colorectal carcinogenesis.PPARGC1A基因的遗传变异可能会影响饮食相关炎症在结直肠癌发生中的作用。
Oncotarget. 2017 Jan 31;8(5):8550-8558. doi: 10.18632/oncotarget.14347.
8
Surveillance after curative treatment for colorectal cancer.结直肠癌治愈性治疗后的监测。
Nat Rev Clin Oncol. 2017 May;14(5):297-315. doi: 10.1038/nrclinonc.2016.199. Epub 2016 Dec 20.
9
A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.两种粪便免疫化学试验(FIT)检测血红蛋白的比较效果试验。在基于人群的结直肠癌筛查计划中的一轮中评估检测性能和依从性。
Gut. 2018 Mar;67(3):485-496. doi: 10.1136/gutjnl-2016-312716. Epub 2016 Dec 14.
10
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.